Your drug development solution provider

Quantitative determination of fentanyl in newborn pig plasma and cerebrospinal fluid samples by HPLC-MS/MS

8 noviembre, 2017

M.E. Blanco, E. Encinas, O. González, E. Rico, V. Vozmediano, E. Suárez and R.M. Alonso

Genotype-guided dosing of warfarin through modeling and simulation

7 noviembre, 2017

Jiexin Denga, Valvanera Vozmediano, Monica Rodriguez, Larisa H. Cavallari, Stephan Schmidt

Model Informed Pediatric Development Applied to Bilastine: Ontogenic PK Model Development, Dose Selection for First Time in Children and PK Study Design

Valvanera Vozmediano, Ander Sologuren, John C. Lukas, Nerea Leal & Mónica Rodriguez

Current strategies to streamline pharmacotherapy for older adults

Jan-F. Schlender, Valvanera Vozmediano, Adam G. Golden, Monica Rodriguez, Tanay S. Samant, Chakradhar V. Lagishetty, Thomas Eissing, Stephan Schmidt

Integration of preclinical and clinical knowledge to predict intravenous PK in human: bilastine case study.

7 junio, 2016

Vozmediano V, Ortega I, Lukas JC, Gonzalo A, Rodriguez M, Lucero ML. PMID: 23619917

A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach.

Encinas E, Calvo R, Lukas JC, Vozmediano V, Rodriguez M, Suarez E. PMID: 23657896 Similar articles Select item 236199176.

Evaluation of fentanyl disposition and effects in newborn piglets as an experimental model for human neonates.

Rey-Santano C, Mielgo V, Valls-I-Soler A, Encinas E, Lukas JC, Vozmediano V, Suárez E. PMID: 24595018 Free PMC Article Similar articles Select item 237351784.

Impact of poor compliance with levofloxacin and moxifloxacin on respiratory tract infection antimicrobial efficacy: a pharmacokinetic/pharmacodynamic simulation study.

Carral N, Lukas JC, Oteo I, Suarez E. PMID: 25450804 Similar articles Select item 245950183.

Contact us

We wish to know from you,
we wish to help you.

RESPONSIBLE: DYNAKIN S.L. PURPOSE: Respond to your information request. RIGHTS: You have the right to access, rectify and delete the data, as well as other rights, as explained in the additional information. ADDITIONAL INFORMATION:You can consult the additional and detailed information on Data Protection here.

I accept the terms of use.